Sixth International Patient Symposium on Myeloproliferative Neoplasms

November 2, 2011

The Cancer Research & Treatment Fund and the MPN Research Foundation will host the 6th International Patient Symposium for individuals myeloproliferative diseases. Patients attending this symposium will learn the latest research developments and treatment practices from a panel of distinguished MPN researchers and physicians. This symposium offers attendees a unique opportunity to engage guest speakers from the most prestigious cancer centers in the world.

Date:
Wednesday, November 2, 2011

Time:
Registration begins at 7:45 a.m.

Program Time:
8:45 a.m. to 5:30 p.m.

Location:
The University Club of New York*
One West 54th St
New York, NY 10019

Speakers:
Dr. Tiziano Barbui, Ospedali Riuniti di Bergamo
David Boule, CR&T and MPN Research Fdn. Board Member
Dr. Sergio Giralt, Memorial Sloan-Kettering Cancer Center
Dr. Ronald Hoffman, Mount Sinai Medical Center
Dr. Ross Levine, Memorial Sloan-Kettering Cancer Center
Dr. Ruben Mesa, Mayo Clinic
Dr. Shahin Rafii, Weill Cornell Medical Center
Robert Rosen, Chairman, MPN Research Foundation
Dr. Richard T. Silver, Weill Cornell Medical Center
Dr. Jerry Spivak, Johns Hopkins University Hospital
Dr. Srdan Verstovsek, MD Anderson Cancer Center
Dr. Babette Weksler, Weill Cornell Medical Center

Registration Fee: $200 per person; each additional guest is $100. (Included are a continental breakfast and lunch)

Patients attending this symposium will learn the latest research developments and treatment practices from a panel of distinguished MPN researchers and physicians

To reserve your place at the event, please visit  www.crt.org or call CR&T at 212.288.6604 with any questions.

*Jacket and tie are required for men; Business casual for women. No jeans or sneakers.

Subscribe to updates to learn more about available MPN treatments.

Betty

Polycythemia Vera (PV)

Meet Betty

Take the steps you need to help change your prognosis.

x

NEVER MISS AN UPDATE

Get free, timely information on living with an MPN.

Subscribe